In addition, YTHDF2 could inhibit the phosphorylation of STAT3 and the expression of Serpin E2, thereby reducing tumor growth and angiogenesis and resisting the occurrence of inflammatory cancer progression (Fig. 4D). This evidence concerns the gene STAT3 and neoplasm.